
TY  - JOUR
TI  - ACCP College American of Clinical Pharmacy: Tenth Annual Meeting
JO  - Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
VL  - 9
IS  - 3
SN  - 0277-0008
UR  - https://doi.org/10.1002/j.1875-9114.1989.tb04124.x
DO  - doi:10.1002/j.1875-9114.1989.tb04124.x
SP  - 169
EP  - 200
PY  - 1989
ER  - 

TY  - JOUR
TI  - Poster Presentations
JO  - Value in Health
VL  - 11
IS  - 3
SN  - 1098-3015
UR  - https://doi.org/10.1111/j.1524-4733.2008.00383_2.x
DO  - doi:10.1111/j.1524-4733.2008.00383_2.x
SP  - A29
EP  - A311
PY  - 2008
ER  - 

TY  - JOUR
TI  - POSTER ABSTRACTS
JO  - Early Intervention in Psychiatry
VL  - 4
IS  - s1
SN  - 1751-7885
UR  - https://doi.org/10.1111/j.1751-7893.2010.00230.x
DO  - doi:10.1111/j.1751-7893.2010.00230.x
SP  - 38
EP  - 187
PY  - 2010
ER  - 

TY  - JOUR
AU  - Caers, Jo
AU  - Vande broek, Isabelle
AU  - De Raeve, Hendrik
AU  - Michaux, Lucienne
AU  - Trullemans, Fabienne
AU  - Schots, Rik
AU  - Van Camp, Ben
AU  - Vanderkerken, Karin
TI  - Multiple myeloma – an update on diagnosis and treatment
JO  - European Journal of Haematology
VL  - 81
IS  - 5
SN  - 0902-4441
UR  - https://doi.org/10.1111/j.1600-0609.2008.01127.x
DO  - doi:10.1111/j.1600-0609.2008.01127.x
SP  - 329
EP  - 343
KW  - multiple myeloma
KW  - management
KW  - risk stratification
PY  - 2008
AB  - Abstract Multiple myeloma is a plasma cell (PC) malignancy characterized by the accumulation of monoclonal PCs in the bone marrow and the production of large amounts of a monoclonal immunoglobulin or paraprotein. In the past years, new approaches in the diagnosis and treatment were introduced aiming to identify high-risk patients who need proper anti-myeloma treatment. Intensive therapy including autologous hematopoietic stem cell transplantation and the new agents bortezomib, thalidomide, and lenalidomide have improved patients? responses. Further optimalization of the different treatment schedules in well-defined patient groups may prolong their survival. Patient stratification is currently based on patient characteristics, extent of myeloma disease, and associated cytogenetic and laboratory anomalies. More and more gene expression studies are introduced to stratify patients and to individualize therapy.
ER  - 

TY  - JOUR
TI  - Oral Abstracts
JO  - Nephrology
VL  - 15
IS  - s3
SN  - 1320-5358
UR  - https://doi.org/10.1111/j.1440-1797.2010.01336.x
DO  - doi:10.1111/j.1440-1797.2010.01336.x
SP  - 33
EP  - 61
PY  - 2010
ER  - 

TY  - JOUR
AU  - Sanchez-Perez, Javier
AU  - De Frutos, J Ortiz
AU  - Bravo, B García
AU  - Salazar, L Conde
AU  - Muntañola, A Alomar
AU  - De la Cuadra Oyanguren, J
AU  - Fernandez-Redondo, V
AU  - Juanena, D Guimaraens
AU  - Vozmediano, JM Fernandez
AU  - Manrique, P
AU  - Romero, A Miranda
AU  - Alvarez, B Piñeiro
AU  - Serna, M Rodriguez
AU  - Sagrera, C Romaguera
AU  - Pedreño, P Sanchez
AU  - Baldrich, E Serra
AU  - Silvestre, JF
AU  - Vilaplana, J Vilaplana
TI  - P23 Allergic contact sensitization in Spanish patch-tested patients in 2001
JO  - Contact Dermatitis
VL  - 50
IS  - 3
SN  - 0105-1873
UR  - https://doi.org/10.1111/j.0105-1873.2004.0309fe.x
DO  - doi:10.1111/j.0105-1873.2004.0309fe.x
SP  - 186
EP  - 186
PY  - 2004
AB  - Objective:? The first Spanish patch-test study of patients with contact dermatitis was performed in 1977. We aimed to determine the prevalence of hypersensitivity for Spanish standard allergens in patients suspected of contact dermatitis in 2001. Methods:? A total of 3832 patients of 13 dermatological centers were patch-tested with Spanish standard series. Age, gender, occupation, dermatitis site and type, and positive patch test were tabulated. Results:? 2300 female and 1532 male patients, aged 0 to 70 years were observed with contact dermatitis. Origin of eczema was occupational in 16.66% of patients. Eczema was located on hands in 54.34% of cases. Allergic contact dermatitis in 31.02% and irritative contact dermatitis in 15.88% were the most frequent diagnosis. Positive patch tests was observed in 55.11% of patients. Prevalence of positives reaction was obtained with nickel (26.64%), cobalt (9.89%), chrome (8.66%), PPDA (5.27%), thimerosal (5.21%), fragance mix (5.03%), Kathon CG (4.04%) and thiuram mix (2.87%). Conclusions:? The results emphasize that nickel, cobalt, chrome are by far the most common allergens. A increase in the frequency of allergic patch test reactions to nickel has been noted (18,78 in 1977; 26,64 in 2001). However the contact sensitivity to cobalt, chrome and thiuram mix has decreased. Currently, allergy to cosmetics constitutes a significant portion of the cases of contact dermatitis.
ER  - 

TY  - JOUR
TI  - Clinical Pharmacology
JO  - Basic & Clinical Pharmacology & Toxicology
JA  - Basic Clin Pharmacol Toxicol
VL  - 115
IS  - s1
SN  - 1742-7835
UR  - https://doi.org/10.1111/bcpt.12259_2
DO  - doi:10.1111/bcpt.12259_2
SP  - 54
EP  - 91
PY  - 2014
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Pharmacoepidemiology and Drug Safety
JA  - Pharmacoepidemiol Drug Saf
VL  - 28
IS  - S2
SN  - 1053-8569
UR  - https://doi.org/10.1002/pds.4864
DO  - doi:10.1002/pds.4864
SP  - 5
EP  - 586
PY  - 2019
ER  - 

TY  - JOUR
TI  - Naspe Abstracts
JO  - Pacing and Clinical Electrophysiology
VL  - 26
IS  - 4p2
SN  - 0147-8389
UR  - https://doi.org/10.1046/j.1460-9592.2003.t01-2-00165.x
DO  - doi:10.1046/j.1460-9592.2003.t01-2-00165.x
SP  - 929
EP  - 1126
PY  - 2003
ER  - 

TY  - JOUR
TI  - Young Investigators Awards Finalists Abstracts
JO  - Pacing and Clinical Electrophysiology
VL  - 26
IS  - 4p2
SN  - 0147-8389
UR  - https://doi.org/10.1046/j.1460-9592.2003.t01-2-00inv.x
DO  - doi:10.1046/j.1460-9592.2003.t01-2-00inv.x
SP  - 990
EP  - 991
PY  - 2003
ER  - 

TY  - JOUR
TI  - Oral Abstracts
JO  - Pacing and Clinical Electrophysiology
VL  - 26
IS  - 4p2
SN  - 0147-8389
UR  - https://doi.org/10.1046/j.1460-9592.2003.t01-2-00ora.x
DO  - doi:10.1046/j.1460-9592.2003.t01-2-00ora.x
SP  - 929
EP  - 990
PY  - 2003
ER  - 

TY  - JOUR
TI  - 2nd Conference of the International Pediatric Transplant Association Abstracts
JO  - Pediatric Transplantation
VL  - 7
IS  - s4
SN  - 1397-3142
UR  - https://doi.org/10.1034/j.1399-3046.7.s4.6.x
DO  - doi:10.1034/j.1399-3046.7.s4.6.x
SP  - 46
EP  - 132
PY  - 2003
ER  - 

TY  - JOUR
TI  - Proceedings of the Thrombosis and Hemostasis summit of North America: Research abstracts
JO  - American Journal of Hematology
JA  - Am. J. Hematol.
VL  - 87
IS  - S1
SN  - 0361-8609
UR  - https://doi.org/10.1002/ajh.23168
DO  - doi:10.1002/ajh.23168
SP  - S146
EP  - S200
PY  - 2012
ER  - 

TY  - JOUR
TI  - Abstract
JO  - Journal of Neurochemistry
VL  - 78
IS  - S1
SN  - 0022-3042
UR  - https://doi.org/10.1111/jnc.2001.78.s1.1
DO  - doi:10.1111/jnc.2001.78.s1.1
SP  - 1
EP  - 208
PY  - 2001
ER  - 

TY  - JOUR
AU  - Willcocks, Leslie P.
AU  - Currie, Wendy
AU  - Jackson, Sylvie
TI  - In Pursuit of the Re-Engineering Agenda in Public Administration
JO  - Public Administration
VL  - 75
IS  - 4
SN  - 0033-3298
UR  - https://doi.org/10.1111/1467-9299.00078
DO  - doi:10.1111/1467-9299.00078
SP  - 617
EP  - 649
PY  - 1997
AB  - The article examines the findings from longitudinal case study work conducted in the 1992-96 period in two organizations in the United Kingdom health care and post office sectors. The study highlights the many cultural, political and technical issues that emerge in the strategy and implementation of IT-enabled re-engineering projects. The radical re-engineering perspective and model for change presented by Hammer and Champy (1993) are compared against empirical findings. These suggest that the Hammer and Champy advice contains many limitations. The cases show the specific circumstances in which radical re-engineering can be effective, in managerial terms, but also point to conditions under which a unitary perspective on the organization often cannot address adequately many critical political and cultural issues. Moreover, the case histories point to the dangers of an over reliance on a methodological holism that can rarely be delivered in complex large-scale organizations, given the scale of change envisaged; and the difficulties engendered by over-emphasizing the need for transformation, and ?starting again?, and downplaying the role of history and continuity in both the study and management of organizational change.
ER  - 

TY  - JOUR
TI  - Poster Abstracts
JO  - Pacing and Clinical Electrophysiology
VL  - 26
IS  - 4p2
SN  - 0147-8389
UR  - https://doi.org/10.1046/j.1460-9592.2003.t01-2-00pos.x
DO  - doi:10.1046/j.1460-9592.2003.t01-2-00pos.x
SP  - 992
EP  - 1126
PY  - 2003
ER  - 

TY  - JOUR
TI  - Abstracts—Posters
JO  - Alcoholism: Clinical and Experimental Research
JA  - Alcohol Clin Exp Res
VL  - 40
IS  - S1
SN  - 0145-6008
UR  - https://doi.org/10.1111/acer.13084
DO  - doi:10.1111/acer.13084
SP  - 16A
EP  - 247A
PY  - 2016
ER  - 

TY  - JOUR
TI  - Abstract
JO  - Journal of Thrombosis and Haemostasis
JA  - Journal of Thrombosis and Haemostasis
VL  - 5
IS  - S2
SN  - 1538-7933
UR  - https://doi.org/10.1111/j.1538-7836.2007.tb00035.x
DO  - doi:10.1111/j.1538-7836.2007.tb00035.x
SP  - P-W-401
EP  - P-W-701
PY  - 2007
ER  - 

TY  - JOUR
TI  - Educational Exhibits
JO  - Journal of Medical Imaging and Radiation Oncology
JA  - J Med Imaging Radiat Oncol
VL  - 60
IS  - S1
SN  - 1754-9477
UR  - https://doi.org/10.1111/1754-9485.12521
DO  - doi:10.1111/1754-9485.12521
SP  - 191
EP  - 231
PY  - 2016
ER  - 

TY  - JOUR
TI  - ABSTRACTS – Online Panel Discussion (i-Pos)
JO  - International Journal of Rheumatic Diseases
VL  - 11
IS  - s1
SN  - 1756-1841
UR  - https://doi.org/10.1111/j.1479-8077.2008.00373.x
DO  - doi:10.1111/j.1479-8077.2008.00373.x
SP  - A84
EP  - A514
PY  - 2008
ER  - 
